Description

Formulation:
Fluralaner 500 mg, excipient and flavours q.s. ad. 1 Palatable soft chew of 4,000 mg.

Indication:
For the control of infestations of the main ectoparasites in dogs (ticks, fleas and mites) for 12 weeks.

• Treatment and prevention of infestations by fleas (Ctenocephalides felis and Ctenocephalides canis), ticks (Ixodes ricinus, Ixodes hexagonus, Ixodes scapularis, Ixodes holocyclus, Dermacentor reticulatus, Dermacentor variabilis and Rhipicephalus sanguineus (adults and juveniles).
  – Treatment of skin and ear mite infestations: demodicosis (Demodex canis), sarcoptic mange (Sarcoptes scabiei var. canis), otodectic otitis (Otodectes cynotis).
• Treatment and prevention of lice infestations (Linognathus spp.) for 7 weeks.
• Control of allergic dermatitis due to flea bites (DAPP), as part of a therapeutic strategy.
• Prevention of the transmission of Babesia canis (causing canine babesiosis), transmitted by Dermacentor reticulatus ticks.

Dosage and Administration:
Orally, 1 tablet for dogs between 10 and 20 kg live weight, every 3 months.

Commercial Presentation:
Box x 1 soft chewable tablet, Box x 4 soft chewable tablets.